CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.496
EU - Europa 5.182
AS - Asia 4.322
SA - Sud America 593
AF - Africa 164
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.360
RU - Federazione Russa 2.512
SG - Singapore 1.784
CN - Cina 1.089
IT - Italia 681
GB - Regno Unito 585
BR - Brasile 475
HK - Hong Kong 366
VN - Vietnam 355
DE - Germania 342
SE - Svezia 241
FR - Francia 240
IE - Irlanda 223
IN - India 173
BD - Bangladesh 138
KR - Corea 133
FI - Finlandia 110
CA - Canada 75
JP - Giappone 71
NL - Olanda 49
AR - Argentina 42
MX - Messico 41
PL - Polonia 38
ZA - Sudafrica 36
TR - Turchia 35
ID - Indonesia 33
BJ - Benin 30
NG - Nigeria 30
ES - Italia 29
IQ - Iraq 28
AT - Austria 27
TG - Togo 27
UA - Ucraina 24
CO - Colombia 17
UZ - Uzbekistan 16
EC - Ecuador 15
PK - Pakistan 13
VE - Venezuela 12
BE - Belgio 11
PH - Filippine 11
PE - Perù 10
CH - Svizzera 9
AU - Australia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
EG - Egitto 7
GR - Grecia 7
IR - Iran 7
KE - Kenya 7
LT - Lituania 7
PT - Portogallo 7
PY - Paraguay 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IL - Israele 5
JO - Giordania 5
MA - Marocco 5
AL - Albania 4
DZ - Algeria 4
HR - Croazia 4
KZ - Kazakistan 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PA - Panama 4
RO - Romania 4
SN - Senegal 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
HU - Ungheria 2
KH - Cambogia 2
ME - Montenegro 2
MK - Macedonia 2
NP - Nepal 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BH - Bahrain 1
BM - Bermuda 1
BW - Botswana 1
CD - Congo 1
Totale 15.751
Salva come PNG Salva come JPEG
Città #
Moscow 926
Singapore 910
Ashburn 821
Dallas 650
San Jose 606
Chandler 488
Southend 448
Hong Kong 355
Dublin 218
Verona 217
Council Bluffs 181
The Dalles 177
Beijing 176
New York 161
Los Angeles 137
Ho Chi Minh City 121
Jacksonville 101
Redmond 90
Wilmington 79
Lawrence 74
Princeton 74
Bologna 70
Hanoi 70
Tokyo 69
Buffalo 64
Helsinki 62
Ann Arbor 61
Jinan 60
Munich 59
Shenyang 55
Santa Clara 54
São Paulo 51
Hyderabad 48
Redondo Beach 48
London 46
Nanjing 46
Sindelfingen 46
Orem 43
Tianjin 40
Seattle 37
Woodbridge 35
Falkenstein 34
Hebei 34
Milan 34
Warsaw 34
Columbus 33
Montreal 33
Denver 32
Cotonou 30
Houston 30
Abuja 29
Washington 29
Lomé 27
Zhengzhou 27
Brooklyn 26
Rome 26
Guangzhou 25
Hangzhou 24
San Francisco 24
Chicago 23
Turku 23
Changsha 22
Taiyuan 22
Haikou 21
Johannesburg 21
Poplar 20
Stockholm 20
Da Nang 19
Nanchang 19
Ningbo 19
Boston 18
Amsterdam 17
Mexico City 17
Atlanta 16
Chennai 16
Dongguan 16
Jakarta 16
Manchester 16
Tashkent 16
Venice 16
Fairfield 15
Jiaxing 15
Redwood City 15
Naples 14
Phoenix 14
Taizhou 14
Frankfurt am Main 13
Mumbai 13
Rio de Janeiro 13
Biên Hòa 12
Brasília 11
Lappeenranta 11
Norwalk 11
Seoul 11
Vienna 11
Brussels 10
Toronto 10
Ankara 9
Belo Horizonte 9
Haiphong 9
Totale 9.238
Salva come PNG Salva come JPEG
Nome #
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 269
Anti-CCP antibodies and bone 243
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 223
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 215
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 204
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 202
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 191
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 190
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 188
Could γ\δ T-cells explain zoledronic acid adverse events? 187
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 184
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 182
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 182
The obesity paradox and osteoporosis 179
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 179
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 174
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 171
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 171
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 167
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 165
Association between environmental air pollution and rheumatoid arthritis flares 163
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 162
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 159
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 159
Association between acute exposure to environmental air pollution and fragility hip fractures 157
Safety issues and adverse reactions with osteoporosis management 157
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 156
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 155
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 154
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 154
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 151
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 151
Calcium and vitamin D supplementation: when and why 148
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 147
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 146
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 146
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 143
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 143
Rheumatoid arthritis, γδ T cells and bisphosphonates 142
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 141
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 141
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 139
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 139
Changes in bone turnover markers and bone modulators during abatacept treatment 137
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 137
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 137
Correction to: The obesity paradox and osteoporosis 136
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 135
Osteoporosis in Rheumatic Diseases 134
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 134
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 131
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 131
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications 130
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 130
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 129
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 127
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 127
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 126
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 126
Bone health status evaluation in men by means of REMS technology 125
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 125
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 124
Gender disparity in authorship of guidelines and recommendations in rheumatology 120
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 119
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 117
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 114
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 113
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 112
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 111
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 111
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study 110
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 110
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 110
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 109
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 108
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 105
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 103
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 101
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 101
Long-Term Bone Mineral Density Changes in Kidney Transplant Recipients Treated with Denosumab: A Retrospective Study with Nonequivalent Control Group 98
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 97
Balancing benefits and risks in the era of biologics 97
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 97
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 96
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 94
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 94
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 92
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 91
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 91
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 90
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 90
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 90
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 89
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database 88
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 86
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 86
Romosozumab in postmenopausal women with smoldering multiple myeloma: a prospective 12-mo study 83
Impact of Exposure to Environmental Particulate Matter on the Onset of Giant Cell Arteritis 82
Totale 13.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.160
article - articoli 59.783
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 286
patent - brevetti 0
selected - selezionate 0
volume - volumi 91
Totale 120.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024982 40 70 89 125 80 202 54 44 30 43 151 54
2024/20252.632 111 132 104 409 160 79 136 103 402 318 231 447
2025/20268.497 538 391 612 1.453 2.209 542 783 514 518 417 223 297
2026/2027145 145 0 0 0 0 0 0 0 0 0 0 0
Totale 16.029